Background: Although PET has been shown to be highly sensitive in the primary staging of lymphoma, previous studies with small numbers of patients indicated that low-grade NHL may not always be adequately detected by PET. We undertook this study to determine factors influencing the detection of lesions by PET in low-grade NHL and to evaluate the utility of PET in this indication.
Introduction
Positron emission tomography (PET) using fluorine-18 fluorodeoxyglucose ( I8 F-FDG) has emerged as a clinical method for staging and monitoring responses to treatment in a variety of cancers [1] . I8 F-FDG-PET provides information complementary to conventional radiological techniques in lymphoma patients, and it seems to be more accurate than a gallium-67 ( 67 Ga) scan [2, 3] . Recent studies indicate the important role of 18 F-FDG-PET in monitoring response to therapy in lymphoma patients [4] [5] [6] [7] [8] [9] [10] [11] [12] and its potential role in early detection of disease recurrence in routine follow-up [13] . However, most patients included in these studies suffered from Hodgkin's disease (HD) or aggressive non-Hodgkin's lymphoma (NHL) for which the sensitivity and specificity of I8 F-FDG-PET have been found to be high [14] [15] [16] [17] [18] [19] . There is no report specifically addressing the role of 18 F-FDG-PET in low-grade NHL. Preliminary results indicate that the sensitivity of I8 F-FDG-PET may be insufficient for low-grade NHL [20, 21] but other studies reported that I8 F-FDG-PET can correctly identify sites of disease in low-grade NHL [14, 16, 17] . We undertook the present study to determine factors influencing the detection of abnormal lymph node areas by PET in lowgrade NHL and to evaluate the utility of PET in this indication.
Patients and methods

Patients
Forty-two consecutive patients with histologically verified low-grade NHL were included in our study prospectively between September 1994 and October 1999. Patient's characteristics are listed in Table 1 . All patients gave oral informed consent for the PET study which was considered as a routine procedure in their staging.
Routine staging procedures
Routine staging methods at diagnosis included at least clinical examination, laboratory screening, chest X-ray, otorhinolaryngologic examina- [22, 23] .
I8 F-FDG-PET studies
Whole-body PET using 1S F-FDG was performed with a Penn PET 240-H Scanner (UGM Philadelphia, Pennsylvania). 18 F-FDG was produced using an automated synthesizer marketed by the Coincidence Company (Liege, Belgium). 200-300 MBq of I8 F-FDG were administered intravenously and emission scans were recorded 50-90 minutes later. All patients were asked to fast for at least six hours prior to the study. A whole-body acquisition was performed from the cervical to the inguinal region. It consisted of 10-12 separate overlapping acquisitions each covering 12.8 cm and performed during 4 minutes Each subsequent acquisition was performed after a 6.4 cm displacement of the table. The total time of image acquisition was about 50 minutes. Images were reconstructed using filtered back projection with a Hanning filter and were reoriented in transverse, coronal and sagittal planes. Since 1997 we used the technique of iterative reconstruction. A 4 mm voxel size was used. Isotropic 3D resolution was better than 8 mm. PET interpretation was performed in a qualitative manner without attenuation correction for most patients Only recently we also performed transmission scans for attenuation correction (10 of 42 patients). All PET images were analyzed by a physician in the division of nuclear medicine and then reviewed by one investigator (G. Jerusalem or R. Hustinx) without previous knowledge of the results of conventional procedures. Any focus of increased "F-FDG uptake over background not located in areas of normal I8 F-FDG uptake (central nervous system, heart, digestive tract, thyroid, muscles) and/or excretion (urinary tract) was considered positive for tumor. The reference area (background) is taken in an area symmetrical to the one with the lesion, preferably in the same transverse plane, alternatively, when the structure or presence of another organ makes it impossible, we use the same coronal plane. The ratio between abnormal accumulation and a reference area is a minimum of 1.5 and most frequently more than 2, as judged by reference to the color scale (black and white). Furosemide (20 mg in slow intravenous injection) was administered to enhance I8 F-FDG urinary elimination. Diazepam (5 mg) was given orally before "F-FDG administration in most patients to prevent muscular uptake. All patients underwent PET scan prior to any treatment.
Standard of reference
We examined the concordance between routine staging procedures and I8 F-FDG-PET. All studies were realized within one week. A lymph node biopsy was performed for histological diagnosis but for ethical 
Results
Lymph node staging
We first compared the results of conventional staging with those of staging with PET alone on a patient-bypatient basis ( Table 2 ). More lymph node areas involved by NHL were identified by PET in 16 patients. Clinical examination and CT showed more lymph node areas involved in 11 patients. Complementary informations were obtained by the two staging techniques in seven patients. The same disease extension was observed in eight patients, including four patients without lymph node infiltration. PET identified more abnormal lymph node areas in the staging of follicular lymphoma than in the staging of small lymphocytic lymphoma. We then analyzed the entire set of lymph node areas detected in all patients by either PET or conventional staging (Table 3) . PET identified 174 lymph node areas potentially infiltrated by lymphoma compared to 153 areas shown by conventional staging procedures. The lesion detection rate of PET was influenced by the histological subtypes and the location of the lymph nodes. In Table 4 Total number of abnormal lymph node areas detected in all patients by PET or conventional procedures according to their location. 
MALT
IV lymphoma node areas (33% more in group B and 42% more in group C; 40% more in the whole group) than conventional staging procedures. However, PET was inappropriate for the staging of small lymphocytic lymphoma where it detected less than 58% of abnormal lymph node areas demonstrated by conventional procedures. In mantle-cell or MALT lymphoma, the number of patients with lymph node infiltration was to low to permit any conclusion. The total number of abnormal lymph node areas detected by PET for the whole group of patients was higher compared to conventional staging for peripheral (34% more lymph node areas detected) and thoracic (39% more) lymph node areas but not for abdominal or pelvic lymph nodes (26% fewer areas detected) ( Table 4 ).
Extranodal disease
We calculated the sensitivity of PET to detect bone marrow infiltration (number of biopsy-proven marrowpositive PET studies over the number of patients with positive bone marrow biopsies). The sensitivity to detect bone marrow infiltration by lymphoma was unacceptably low for PET (11 of 28 = 39%), independently of the histologic subtype (Table 5 ). In contrast, PET was as effective as standard procedures for the detection of other localizations. However, a few localizations were detected only by PET and a few others only by conventional procedures. PET identified more cases of splenic or hepatic infiltration but CT showed more cases of pleural or lung infiltration. infiltration was not identified. Therefore, a bone marrow biopsy has to be performed in addition to PET in all patients. Thus, if we compare the result of PET plus a bone marrow biopsy to conventional staging procedures (also including a bone marrow biopsy), we observed the same stage in 37 patients (stage I: 2, II: 1, III: 6, IV: 28), a higher stage by PET in 2 patients (stage III instead of II) and a higher stage by conventional procedures in 3 patients (stage III vs. II, II vs. 0 and IV vs. 0) ( Table 6 ). Based on our study design, a histological confirmation of an unknown lesion detected only by PET was done only when considered clinically necessary. However, PET results never changed the treatment strategy in our patients. Therefore, the PET results were not used to indicate further conventional examinations. Examples of 18 F-FDG-PET studies are illustrated in Figures 1-3 .
Overall results: Comparison of all standard procedures
Discussion versus I8 F-FDG-PET The use of 18 [20, [24] [25] [26] , the Ki-67 labeling index [24] or the number of cells in S-phase [25] . Conflicting data have been published about the sensitivity of 18 F-FDG-PET in lowgrade NHL. Newman et al. [14] studied six patients with low-grade NHL and found that 18 F-FDG uptake was comparable to that observed in intermediate-grade NHL. Moog et al. [16] described sufficient 18 F-FDG uptake in five patients with low-grade NHL to produce adequate contrast to normal tissue. Stumpe et al. [17] reported prominent I8 F-FDG uptake by sites involved by disease in six patients. In contrast, Leskinen-Kallio et al. [20] observed poor 18 F-FDG uptake in three of five patients with low-grade NHL. More recently, disappointing results have been shown in all nine patients undergoing PET for staging of low-grade extranodal B-cell lymphomas of the MALT type [21] . PET documented no focal tracer uptake either in gastric or extragastric lesions or in involved lymph nodes.
To the best of our knowledge, this study is the first including a high number of patients with low-grade NHL undergoing staging by I8 F-FDG-PET. The most important finding is that 18 F-FDG-PET if combined with a bone marrow biopsy identified more lesions and gave complementary information to conventional procedures for the staging of follicular NHL. This implies that PET may be useful for monitoring therapy results in this group of patients. However, this remains to be proven in prospective studies. Interestingly, 67 Ga scan depends also on the histological subtype [27] . The sensitivity of 67 Ga-scans is also high in follicular lymphoma and low in MALT and small lymphocytic lymphoma.
Another new finding of our study is that PET identified more peripheral or thoracic lymph nodes compared to abdominal localizations. Similar results have been published for 67 Ga scans [28] [29] [30] [31] [32] [33] [34] [35] . I8 F-FDG-PET is complementary to standard procedures for the detection of extranodal disease. However, its sensitivity is unacceptably low for the detection of bone marrow infiltration. Only a bone marrow biopsy is appropriate for bone marrow staging. PET should be added to the conventional staging procedures.
The technical conditions of our study have to be considered. The machine used is not a last generation PET scanner. We have not performed attenuation correction until recently when we have acquired a new system using a single photon source (cesium-137) for transmission studies. We did not perform a semi-quantitative analysis (standard uptake value: SUV) for interpretation of our data. The optimal detection of abdominal or pelvic lymph nodes might be improved by these factors. However, it remains to be demonstrated that attenuation correction needs to be performed for the primary staging of malignant lymphoma by I8 F-FDG-PET. Kotzerke et al. [36] evaluated retrospectively 51 untreated patients with either NHL (n = 29) or HD (n = 22). In this study attenuation correction did not improve the diagnostic accuracy of 18 F-FDG-PET for the detection of lymph node or organ infiltration during the primary staging of lymphoma. Unfortunately, a histological proof could not be used as the golden standard because systematic biopsies of the various sites possibly involved by disease could not be performed for ethical reasons. This limitation is inherent to all imaging studies in the field of lymphoma. Another possible weakness of our study is the small number of patients and the heterogeneity of the histopathological subtypes making some subgroup analyses difficult to interpret. Confirmation of our data on a larger number of patients studied in the best technical conditions is warranted.
In conclusion, the results of the present study indicate that 18 F-FDG-PET may contribute to the management of patients with low-grade follicular NHL. I8 F-FDG-PET identified more lesions or gave complementary information to conventional procedures for staging follicular lymphoma. Further studies should investigate the potential role of PET to evaluate the results of therapy or to diagnose disease recurrence. For the other subtypes of low-grade lymphoma, the role of PET is less demonstrative. Further quantitative studies are warranted to determine whether I8 F-FDG uptake at diagnosis has prognostic value and may thus contribute to establish treatment guidelines.
